Medi-Tate is a medical device manufacturer engaged in the research and development, production, and sale of devices for the minimally invasive treatment of BPH. The company’s flagship product iTind has received U.S. FDA de Novo authorization and a European CE mark. With its initial Medi-Tate investment, Olympus has had the right of distribution since November 2018.
- Read more about Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/olympus-acquires-israeli-medical-device-company-medi-tate-to-drive-global-urology-business-growth
No comments:
Post a Comment